1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine
C166H221N31O — CID 158825186
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine
1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine (PubChem CID 158825186) has the molecular formula C166H221N31O and a molecular weight of 2666.81 g/mol. Its IUPAC name is 1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine.
Molecular Properties
| Compound Name | 1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine |
|---|---|
| PubChem CID | 158825186 |
| Molecular Formula | C166H221N31O |
| Molecular Weight | 2666.81 g/mol |
| Exact Mass | 2664.82 |
| IUPAC Name | 1,2-dimethyl-5-propan-2-ylbenzimidazole;1,3-dimethyl-6-propan-2-ylindazole;1,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;2,7-dimethyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1-ethyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;1-methyl-5-propan-2-ylbenzotriazole;1-methyl-5-propan-2-yl-3-pyridin-2-ylindazole;1-methyl-5-propan-2-yl-3-pyridin-3-ylindazole;1-methyl-4-(4-propan-2-yl-2-pyridinyl)piperazine;2-propan-2-yl-3,4-dihydro-1H-isoquinoline;1-propan-2-yl-4-(4-propan-2-yl-2-pyridinyl)piperazine;4-(4-propan-2-yl-2-pyridinyl)morpholine |
| SMILES | CC(C)N1CCc2ccccc2C1.CC(C)c1ccc2c(c1)c(-c1ccccn1)nn2C.CC(C)c1ccc2c(c1)c(-c1cccnc1)nn2C.CC(C)c1ccc2c(c1)nnn2C.CC(C)c1ccnc(N2CCN(C(C)C)CC2)c1.CC(C)c1ccnc(N2CCN(C)CC2)c1.CC(C)c1ccnc(N2CCOCC2)c1.CCN1CCN(c2cc(C(C)C)ccn2)CC1.Cc1cc(-c2cc(C(C)C)ccn2)cc2cn(C)nc12.Cc1cc(-c2cc(C(C)C)ccn2)cc2cnn(C)c12.Cc1nc2cc(C(C)C)ccc2n1C.Cc1nn(C)c2cc(C(C)C)ccc12 |
| InChI | InChI=1S/2C17H19N3.2C16H17N3.C15H25N3.C14H23N3.C13H21N3.C12H18N2O.2C12H16N2.C12H17N.C10H13N3/c1-11(2)13-5-6-18-16(9-13)14-7-12(3)17-15(8-14)10-20(4)19-17;1-11(2)13-5-6-18-16(9-13)14-7-12(3)17-15(8-14)10-19-20(17)4;1-11(2)12-6-7-15-14(9-12)16(18-19(15)3)13-5-4-8-17-10-13;1-11(2)12-7-8-15-13(10-12)16(18-19(15)3)14-6-4-5-9-17-14;1-12(2)14-5-6-16-15(11-14)18-9-7-17(8-10-18)13(3)4;1-4-16-7-9-17(10-8-16)14-11-13(12(2)3)5-6-15-14;1-11(2)12-4-5-14-13(10-12)16-8-6-15(3)7-9-16;1-10(2)11-3-4-13-12(9-11)14-5-7-15-8-6-14;1-8(2)10-5-6-12-11(7-10)13-9(3)14(12)4;1-8(2)10-5-6-11-9(3)13-14(4)12(11)7-10;1-10(2)13-8-7-11-5-3-4-6-12(11)9-13;1-7(2)8-4-5-10-9(6-8)11-12-13(10)3/h2*5-11H,1-4H3;2*4-11H,1-3H3;5-6,11-13H,7-10H2,1-4H3;5-6,11-12H,4,7-10H2,1-3H3;4-5,10-11H,6-9H2,1-3H3;3-4,9-10H,5-8H2,1-2H3;2*5-8H,1-4H3;3-6,10H,7-9H2,1-2H3;4-7H,1-3H3 |
| InChIKey | IWJDXDRPHCGLIZ-UHFFFAOYSA-N |
| XLogP | 35.29 |
| TPSA | 275.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 198 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2666.81 |
| LogP ≤ 5 | 35.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158825186 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.